US Archives - Page 12 of 99 - European Medical Journal

HER2-Targeted Therapy Extends Gastric Cancer Survival: ASCO 2025

Second-line treatment with trastuzumab deruxtecan has been shown to extend overall survival by more than 3 months in patients with advanced HER2-positive gastric or gastroesophageal junction adenocarcinoma (GEJA) following progression on first-line therapy, according to Phase III data from the DESTINY-Gastric04 trial presented at the ASCO 2025 Annual Meeting.

Earlier Geriatric Assessment Improves Hip Fracture Outcomes

Early geriatric assessments in older adults with hip fractures are strongly associated with improved recovery, reduced hospital stays, and lower complication rates, according to a new systematic review.

Vagus Nerve Stimulation Linked to Quality of Life Gains in Epilepsy

Vagus nerve stimulation (VNS) not only reduces seizures in patients with epilepsy but also leads to early and sustained improvements in mental health, sleep, and quality of life, according to a new multicenter cohort study.

ES-SCLC Maintenance Outcomes from IMforte Trial: ASCO 2025

First-line maintenance treatment with lurbinectedin and atezolizumab significantly improves survival outcomes in patients with extensive-stage small cell lung cancer (ES-SCLC), according to primary results from the global Phase III IMforte trial presented at ASCO 2025.

New Oral Therapy Doubles PFS in ESR1+ Breast Cancer: ASCO 2025

A NEW oral therapy may significantly delay disease progression in patients with ESR1-mutated, ER-positive, HER2-negative advanced breast cancer, according to results presented at the 2025 ASCO Annual Meeting.

Severe Pediatric Conditions Drive Hospital Resource Strain

Children with complex chronic diseases (C-CDs) and life-limiting conditions (LLCs) account for a disproportionate share of pediatric hospital admissions and resource use, according to a new retrospective study conducted in the Basque Public Health System.

Pneumococcal Disease Threat Rises for Veterans Post-Flu

VETERANS hospitalized with influenza or respiratory syncytial virus (RSV) face a significantly elevated risk of secondary Streptococcus pneumoniae infection, while those with COVID-19 appear to have a reduced risk, according to a new national retrospective study spanning a decade of Veterans Affairs hospital data.

Which Therapies Help Pediatric Rheumatic Fatigue?

A new systematic review has found limited and inconsistent evidence for the effectiveness of current fatigue-reducing interventions in children and adolescents with pediatric rheumatic diseases (PRDs), underscoring the urgent need for more rigorous and targeted clinical research.

Clinical Update: Psoriasis Care During Pregnancy and Breastfeeding

Psoriasis in pregnancy and lactation presents critical challenges for clinical management, according to a new review aimed at dermatologists and healthcare professionals.

Optimizing Patient Care in MIBC with MRD Testing

Explore how circulating tumor DNA (ctDNA) testing enables earlier detection of disease recurrence…